Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- I. Litvan, J. Goldman, M. Emre
- Psychology, MedicineMovement Disorders
- 1 March 2012
These diagnostic criteria will support future research efforts to identify at the earliest stage those PD patients at increased risk of progressive cognitive decline and dementia who may benefit from clinical interventions at a predementia stage.
Clinical diagnostic criteria for dementia associated with Parkinson's disease
- M. Emre, D. Aarsland, B. Dubois
- Psychology, MedicineMovement Disorders
- 15 September 2007
Clinical diagnostic criteria for probable and possible PD‐D are proposed, characterized by impairment in attention, memory, executive and visuo‐spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent.
Diagnosis and management of dementia with Lewy bodies
- I. McKeith, D. Dickson, M. Yamada
- Medicine, PsychologyNeurology
- 27 December 2005
The authors propose a new scheme for the pathologic assessment of LBs and Lewy neurites (LN) using alpha-synuclein immunohistochemistry and semiquantitative grading of lesion density, with the pattern of regional involvement being more important than total LB count.
Diagnosis and management of dementia with Lewy bodies
- I. McKeith, B. Boeve, K. Kosaka
- Medicine, BiologyNeurology
- 4 July 2017
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for…
Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
The main focus of this article is to operationalize the diagnosis of PD‐D and to propose pratical guidelines based on a two level process depending upon the clinical scenario and the expertise of the evaluator involved in the assessment.
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's…
- G. Stebbins, C. Goetz, D. Burn, J. Jankovic, T. Khoo, B. Tilley
- Psychology, BiologyMovement Disorders
- 1 May 2013
TD and PIGD designations, based on the original Unified Parkinson's Disease Rating Scale (UPDRS), provided useful designations for classifying different phenotypes of PD, but a valid set of calculations for these phenotypes is needed.
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
- I. Litvan, K. Bhatia, G. Wenning
- Medicine, PsychologyMovement Disorders
- 1 May 2003
This review summarizes the findings of the SIC Task Force for the study of diagnostic criteria for parkinsonian disorders in the areas of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, and corticobasal degeneration.
Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
- E. Burton, I. McKeith, D. Burn, E. Williams, J. O'Brien
- Psychology, MedicineBrain : a journal of neurology
- 1 April 2004
The aim of this cross-sectional study was to establish the pattern of cerebral atrophy on MRI in Parkinson's disease patients with dementia, and voxel-based morphometry (VBM) was used to provide an unbiased means of investigating brain volume loss.
Life with communication changes in Parkinson's disease.
- N. Miller, E. Noble, Diana E Jones, D. Burn
- PsychologyAge and Ageing
- 1 May 2006
Speech and language changes in PD impact upon individual and family life long before frank impairment of intelligibility is apparent, and the role of early referral to speech and language therapy is therefore worthy of detailed investigation.
Mild cognitive impairment in Parkinson disease
- D. Aarsland, K. Brønnick, M. Emre
- Psychology, MedicineNeurology
- 21 September 2010
Having MCI was associated with older age at assessment and at disease onset, male gender, depression, more severe motor symptoms, and advanced disease stage, and future studies of patients with PD with MCI need to determine risk factors for ongoing cognitive decline and assess interventions at a predementia stage.
...
...